跳至主要内容
临床试验/NCT02475187
NCT02475187终止不适用

Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture

Vestre Viken Hospital Trust1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
33
试验地点
1
主要终点
Measurements of thrombogenic properties by TEG (Maximum Amplitude) and MEA (Units) and thrombotic events in 220 patients with Hip Fracture.

研究概览

简要总结

Measurement of thrombogenic properties by TEG and MEA and observation of thrombotic events over 2 years in 220 patients with hip fracture.

详细描述

Patients with proximal femur fracture have high incidences of thrombotic events. By the two "bed-side" methods TEG (Thrombelastography) and MEA (Multiple Electrode Aggregometry), the thrombogenic properties of 220 patients with proximal femur fracture will be measured at time of hospital admission and 4 times over a period of 6 months postoperatively, and the patients will be followed in a total length of 2 years to register thrombotic events.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 18 years who are admitted to our hospital for orthopedic surgery of proximal femur fracture.
  • The study participants must be capable to sign/accept informed concent

排除标准

  • Patients with severe dementia or that of other causes not ar capable to give informed concent.
  • Patients with known or suspected cancer, blood diseases or bleeding disorders
  • Surgery last 6 months
  • Severe renal- (eGFR (creatinine) <30)
  • Severe hepatic failure (2x UNL for bilirubin, 3x UNL for ALAT or INR > 1,3 without anticoagulation treatment)
  • Patients that, by drug spesification or -SPC, not are eligible for postoperative thrombosis prophylaxis

结局指标

主要结局

Measurements of thrombogenic properties by TEG (Maximum Amplitude) and MEA (Units) and thrombotic events in 220 patients with Hip Fracture.

时间窗: 24 months

Thrombogenic properties measured by TEG (different measurements as "MA") and MEA (measured as "U") 6 months after operation for hip fracture and clinical thrombotic events over 24 months

次要结局

  • Measurements of thrombogenic properties by TEG (Maximum amplitude) and MEA (Units)) in the 100 patients with Hip Fracture and thrombotic complications(6 months)
  • Measurements of thrombogenic properties by TEG (Maximum Amplitude) and MEA (Units) in 220 patients with Hip Fracture.(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验